SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-10-054340
Filing Date
2010-10-28
Accepted
2010-10-28 16:15:45
Documents
3
Period of Report
2010-10-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a10-20130_18k.htm 8-K 28877
2 EX-99.1 a10-20130_1ex99d1.htm EX-99.1 162227
3 GRAPHIC g201301mmi001.jpg GRAPHIC 3090
  Complete submission text file 0001104659-10-054340.txt   197188
Mailing Address 100 HAYDEN AVENUE LEXINGTON MA 02140
Business Address 100 HAYDEN AVENUE LEXINGTON MA 02140 6174972070
AMAG PHARMACEUTICALS INC. (Filer) CIK: 0000792977 (see all company filings)

IRS No.: 042742593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-10865 | Film No.: 101148360
SIC: 2835 In Vitro & In Vivo Diagnostic Substances